HRP20160293T1 - Formulacije za kontrolu pretilosti koje sadrže saccharomyces boulardii i superoksid-dismutazu - Google Patents

Formulacije za kontrolu pretilosti koje sadrže saccharomyces boulardii i superoksid-dismutazu Download PDF

Info

Publication number
HRP20160293T1
HRP20160293T1 HRP20160293TT HRP20160293T HRP20160293T1 HR P20160293 T1 HRP20160293 T1 HR P20160293T1 HR P20160293T T HRP20160293T T HR P20160293TT HR P20160293 T HRP20160293 T HR P20160293T HR P20160293 T1 HRP20160293 T1 HR P20160293T1
Authority
HR
Croatia
Prior art keywords
preparation
superoxide dismutase
reduce
formulations
obesity
Prior art date
Application number
HRP20160293TT
Other languages
English (en)
Inventor
Ignazio CASTAGLIUOLO
Paola BRUN
Immacolata Busiello
Niccolò MIRAGLIA
Original Assignee
Gnosis S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gnosis S.P.A. filed Critical Gnosis S.P.A.
Publication of HRP20160293T1 publication Critical patent/HRP20160293T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/446Superoxide dismutase (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Claims (6)

1. Pripravak koji sadrži Saccharomyces cerevisiae var boulardii i enzim superoksid-dismutazu.
2. Pripravak kako je prijavljen u patentnom zahtjevu 1, naznačen time superoksid-dismutaza jest u želučano otpornom obliku.
3. Pripravak kako je prijavljen u patentnom zahtjevu 1 ili 2 u obliku paketa, naznačen time da je pogodan za istodobno, odvojeno ili uzastopno davanje.
4. Pripravak iz patentnog zahtjeva 1, 2 ili 3, naznačen time da se upotrebljava za dodatak dijeti.
5. Pripravak iz patentnih zahtjeva 1 ili 2, naznačen time da se upotrebljava za sprječavanje ili redukciju rizika od razvitka metaboličkih disfunkcija povezanih s pretilošću.
6. Pripravak iz patentnih zahtjeva 1 ili 2, naznačen time da se upotrebljava za smanjivanje povećanja mase, za smanjivanje uzimanja hrane, za smanjivanje akumulacije tjelesnog masnog tkiva te za poboljšanje sistemskog upalnog stanja povezanog s pretilošću.
HRP20160293TT 2011-08-03 2016-03-22 Formulacije za kontrolu pretilosti koje sadrže saccharomyces boulardii i superoksid-dismutazu HRP20160293T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001488A ITMI20111488A1 (it) 2011-08-03 2011-08-03 Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
EP12750344.9A EP2739295B1 (en) 2011-08-03 2012-08-02 Formulations comprising saccharomyces boulardii and superoxide dismutase for controlling obesity
PCT/EP2012/065119 WO2013017650A2 (en) 2011-08-03 2012-08-02 Formulations containing saccharomyces boulardii and superoxide dismutase (sod) to control obesity

Publications (1)

Publication Number Publication Date
HRP20160293T1 true HRP20160293T1 (hr) 2016-04-22

Family

ID=44675697

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20160293TT HRP20160293T1 (hr) 2011-08-03 2016-03-22 Formulacije za kontrolu pretilosti koje sadrže saccharomyces boulardii i superoksid-dismutazu

Country Status (25)

Country Link
US (1) US9555082B2 (hr)
EP (1) EP2739295B1 (hr)
JP (1) JP6126595B2 (hr)
KR (1) KR101954674B1 (hr)
CN (1) CN103764156A (hr)
AU (1) AU2012292029B2 (hr)
BR (1) BR112014001336A2 (hr)
CA (1) CA2843794C (hr)
CY (1) CY1117187T1 (hr)
DK (1) DK2739295T3 (hr)
ES (1) ES2562647T3 (hr)
GE (1) GEP20166436B (hr)
HR (1) HRP20160293T1 (hr)
HU (1) HUE027121T2 (hr)
IL (1) IL230723B (hr)
IT (1) ITMI20111488A1 (hr)
MX (1) MX349242B (hr)
PL (1) PL2739295T3 (hr)
RS (1) RS54594B1 (hr)
RU (1) RU2600843C2 (hr)
SI (1) SI2739295T1 (hr)
SM (1) SMT201600086B (hr)
UA (1) UA112990C2 (hr)
WO (1) WO2013017650A2 (hr)
ZA (1) ZA201400758B (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2870969A1 (fr) * 2013-11-08 2015-05-13 Biocodex Composition pharmaceutique pour la réduction de la masse adipeuse
KR101893735B1 (ko) * 2018-05-04 2018-08-31 주식회사이-글벳 열 안정성이 강화된 효모를 이용한 정장효능이 있는 산제 동물용 의약품 조성물 및 그 제조 방법
WO2024002150A1 (en) * 2022-06-29 2024-01-04 Microbiota I - Center (Magic) Limited Methods and compositions for treating obesity using microorganisms

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62215532A (ja) * 1986-03-18 1987-09-22 Ube Ind Ltd 抗炎症剤
FR2825004B1 (fr) * 2001-05-22 2005-02-11 Bio Springer Produit dietetique satiant
US20060008511A1 (en) * 2004-07-08 2006-01-12 Jhy-Jhu Lin Probiotic products for pet applications
US7935334B2 (en) * 2005-07-07 2011-05-03 Imagilin Technologies, LLC Probiotics as alternative medicines against infectious diseases
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
SE529185C2 (sv) 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
CN101172118A (zh) 2006-07-26 2008-05-07 美国医迈科技有限公司 作为抗传染病替代药物的益生微生物
KR20080094459A (ko) * 2007-04-20 2008-10-23 주식회사 엘지생활건강 항산화 활성을 갖는 화장료 조성물
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
CN101130068B (zh) * 2007-09-04 2010-05-19 陈坤鑫 Sod减肥酒及其生产方法
LT2227539T (lt) * 2007-12-26 2017-11-27 Lesaffre Et Compagnie Žmonių ir (arba) gyvūnų mitybai skirta kompozicija, jos panaudojimas ir mielės
BRPI0907875A2 (pt) * 2008-02-14 2015-07-21 Barley & Oats Co Ltd Produto fermentado produzido por adição de microorganismo comestível e método para produzir produto fermentado
US20110091553A1 (en) * 2008-06-02 2011-04-21 Kaneka Corporation Method for producing microcapsules using solid fat
JP2010100530A (ja) * 2008-10-21 2010-05-06 Ikeda Shokken Kk 抗肥満剤
WO2010083227A1 (en) * 2009-01-14 2010-07-22 Nutrafood Nutrients, Inc. Consumable dissolving film comprising active ingredients derived from bacteria and fungi
EP2216036A1 (en) 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
DK3181134T3 (da) 2009-06-19 2020-01-20 Dupont Nutrition Biosci Aps Bifidobakterier til behandling af diabetes og relaterede tilstande
JP2011004640A (ja) * 2009-06-24 2011-01-13 Kaneka Corp 魚介エキスの精製方法
US20120121562A1 (en) * 2009-07-31 2012-05-17 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
IT1396074B1 (it) * 2009-10-12 2012-11-09 Axioma S R L Composizione ad attivita' termogenetica potenziata e suo impiego nella prevenzione e trattamento dell'obesita'

Also Published As

Publication number Publication date
HUE027121T2 (en) 2016-08-29
RS54594B1 (en) 2016-08-31
KR20140051279A (ko) 2014-04-30
PL2739295T3 (pl) 2016-06-30
UA112990C2 (uk) 2016-11-25
BR112014001336A2 (pt) 2017-07-04
CA2843794C (en) 2021-11-09
ZA201400758B (en) 2015-10-28
CY1117187T1 (el) 2017-04-05
DK2739295T3 (en) 2016-03-14
US9555082B2 (en) 2017-01-31
WO2013017650A2 (en) 2013-02-07
ITMI20111488A1 (it) 2013-02-04
SI2739295T1 (sl) 2016-04-29
JP2014521343A (ja) 2014-08-28
CA2843794A1 (en) 2013-02-07
US20140205581A1 (en) 2014-07-24
EP2739295B1 (en) 2015-12-30
SMT201600086B (it) 2016-04-29
KR101954674B1 (ko) 2019-03-06
GEP20166436B (en) 2016-02-25
WO2013017650A3 (en) 2013-04-04
AU2012292029B2 (en) 2017-03-09
AU2012292029A1 (en) 2014-02-20
MX349242B (es) 2017-07-18
RU2600843C2 (ru) 2016-10-27
RU2014103483A (ru) 2015-08-10
NZ620579A (en) 2015-11-27
CN103764156A (zh) 2014-04-30
IL230723B (en) 2018-01-31
ES2562647T3 (es) 2016-03-07
MX2014001327A (es) 2014-02-27
IL230723A0 (en) 2014-03-31
EP2739295A2 (en) 2014-06-11
JP6126595B2 (ja) 2017-05-10

Similar Documents

Publication Publication Date Title
WO2011106423A3 (en) Acai and iridoid based formulations
JP2008183013A5 (hr)
HRP20160293T1 (hr) Formulacije za kontrolu pretilosti koje sadrže saccharomyces boulardii i superoksid-dismutazu
WO2010012408A3 (de) Mikroemulsion
JP2012532098A5 (hr)
WO2016019400A3 (en) Functional-gel compositions methods
BRPI0820068B8 (pt) uso de cepa de levedura e/ou de uma composição compreendendo cepa de levedura para preparação de um medicamento
WO2011106448A3 (en) Iridoid based formulations
WO2011056487A3 (en) Stable thickener formulations
WO2011106432A3 (en) Morinda citrifolia and iridoid based formulations
WO2011150364A3 (en) Therapeutic food formulation
WO2015024577A3 (fr) Composition a base de safranal
BR112013002176A2 (pt) recheio de gorgura com gordura vegetal e adoçante
WO2013166420A3 (en) Liquid crystalline phytosterol-glycerine complex for enhanced bioavailability and water dispersal
WO2013052433A3 (en) Methods and compositions for reducing food intake and body weight gain in animals
Yun et al. Effect of the supplementation of Coconopsis lanceolata extract on lipid metabolism amelioration in type 2 diabetes mouse model induced by high fat diet
EP2505074A3 (en) Use of whole grain - hydrocolloid complexes produced by heat-moisture treatment for satiety, reduction of food intake and weight management
JP2011084554A5 (hr)
PL398166A1 (pl) Guma do zucia ulatwiajaca odchudzanie
TWM503903U (zh) 促進老化細胞再活化之草藥萃取物之晶粒結構
CN102948661A (zh) 具有刺激大肠蠕动预防肠癌功效的保健品
TH138990A (th) ผลกระทบทางเมตาบอลิคของลิปิดที่ได้รับการจัดโครงสร้าง
Keyrouz Design and competitive considerations in the research development, and launch of pharmaceutical products in the Lebanese market.(c2010)
Jo et al. Physiological activity and nutritional composition of Pleurotus species
Abe Eco-physiological studies on the migration limited in freshwater areas and spawning of kissing loach: Adaptations of teleost fishes to floodplain environments